Today: 19 April 2026
Costco Says No Special Dividend Yet as Digital Personalization Drives $470 Million in Sales
9 March 2026
2 mins read

Costco Says No Special Dividend Yet as Digital Personalization Drives $470 Million in Sales

ISSAQUAH, Washington, March 9, 2026, 08:38 (UTC-07:00)

Costco isn’t rolling out a special dividend right now, despite its cash reserves bouncing back and new digital recommendation tools bringing in upwards of $470 million from e-commerce during the second quarter. Shares ticked up roughly 0.4% early Monday.

This is coming up now because Costco posted a quarterly beat, and investors want clarity: will the company deploy its extra cash into upgrading warehouses and tech, or opt to send some back to shareholders? The discussion is surfacing as Costco doubles down on personalization efforts, all while sticking to its hallmark low-price promise—key for keeping shoppers, especially with consumers still on uneven footing.

Comparable sales—stripping out gas prices and currency moves—were up 6.7%, topping analyst forecasts for a 5.88% gain, LSEG data showed. Net sales hit $68.24 billion, a 9.1% increase, while net income reached $2.04 billion, up almost 14%.

During the March 5 earnings call, Costco CFO Gary Millerchip made it clear: the company’s cash game plan is sticking to the script. Top of the list—funding new warehouses, adding distribution depots, and putting money into digital. Regular dividend keeps ticking higher, buybacks still just enough to match stock compensation. As for a special dividend? Still on the table for surplus cash, but Millerchip said there are “no plans” for one right now. The Motley Fool

Costco’s latest filing shows the company wrapped up Feb. 15 sitting on $17.38 billion in cash and cash equivalents—up from $14.16 billion at August’s close. Millerchip noted the balance has rebounded to pre-special-dividend heights, but matching the previous yield would take more cash this time around, since shares have climbed. December’s special dividend? $15 a share, totaling roughly $6.7 billion.

Digital factors have resurfaced in the cash debate. Millerchip pointed to personalized product recommendation carousels, which brought in over $470 million in e-commerce sales for the quarter. Site traffic climbed 32%, app visits jumped 45%, and digitally enabled comparable sales advanced 22.6%. These shifts, he said, are delivering “measurable impacts.” The Motley Fool

Costco isn’t abandoning its core playbook even as it ramps up its toolkit. With consumers squeezed by rent and fuel bills, warehouse clubs and big-box names like Walmart are drawing traffic from across the income spectrum. Costco’s Kirkland Signature label, meanwhile, keeps undercutting national brands with cheaper options.

The company has said that any tariff refunds will be returned to pricing. Chief Executive Ron Vachris told reporters it’s still uncertain if or when those refunds might come through, but Costco’s plan is to cut prices and boost value for customers should they receive the funds.

Analysts point to consistent demand combined with tight price controls as a positive for Costco. David Wagner, who runs equities at Aptus Capital Advisors, thinks the retailer’s reputation as a “safe haven” could stick, especially with geopolitical risks swirling. Over at D.A. Davidson, analyst Michael Baker noted that with inflation cooling, Costco’s been able to share some of those cost breaks with shoppers. Reuters

But it’s hardly straightforward. Vachris described tariffs as “extremely fluid.” Millerchip flagged the risk: extended Middle East unrest might drive up fuel prices and unsettle shipping. Renewal rates for U.S. and Canada nudged down 0.1 percentage point quarter-over-quarter—more signups happened online, and those tend to renew less often. The Motley Fool

Costco wrapped up the quarter sitting on 82.1 million paid memberships, with membership fee income climbing 13.6%, and its global warehouse count reaching 924. That reliable influx from fees keeps drawing investor focus to cash returns, though management still points discussions toward expanding store count and boosting digital investments.

Stock Market Today

  • Ford, GM, Stellantis Stocks Rise in Week Ending April 17
    April 19, 2026, 9:06 AM EDT. Ford Motor Co., General Motors, and Stellantis posted stock gains for the week ending April 17, 2026. Ford's shares rose 6.1% to $12.87, General Motors increased 6.41% to $81.32, and Stellantis climbed 7.21% to $8.62. The Detroit Three automakers experienced notable stock price fluctuations during the week amid broader market dynamics. Investors responded to sector developments, including leadership changes at Ford, defense collaborations involving GM and Ford, and Stellantis' strong North American vehicle shipments. Market hours run from 9:30 a.m. to 4 p.m. Eastern Time, Monday through Friday.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 19.04.2026

19 April 2026
LIVEMarkets rolling coverageStarted: April 19, 2026, 12:00 AM EDTUpdated: April 19, 2026, 9:17 AM EDT Ford, GM, Stellantis Stocks Rise in Week Ending April 17 April 19, 2026, 9:06 AM EDT.Ford Motor Co., General Motors, and Stellantis posted stock gains for the week ending April 17, 2026. Ford's shares rose 6.1% to $12.87, General Motors increased 6.41% to $81.32, and Stellantis climbed 7.21% to $8.62. The Detroit Three automakers experienced notable stock price fluctuations during the week amid broader market dynamics. Investors responded to sector developments, including leadership changes at Ford, defense collaborations involving GM and Ford, and Stellantis' strong
Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Jefferies Financial Group Inc Says MFS Losses Seen Under $20 Million as Western Alliance Clash Deepens
Previous Story

Jefferies Financial Group Inc Says MFS Losses Seen Under $20 Million as Western Alliance Clash Deepens

Stock Market Today: Wall Street Slides as Oil Nears $120 and Weak Jobs Data Stoke Stagflation Fears
Next Story

Stock Market Today: Wall Street Slides as Oil Nears $120 and Weak Jobs Data Stoke Stagflation Fears

Go toTop